Patent 5776433 Issued on July 7, 1998. Estimated Expiration Date: July 7, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Pharmaceutical aerosol formulations substantially free of chlorofluorocarbons and comprising a therapeutically effective amount of flunisolide in solution with ethanol and a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane and a mixture thereof are used for the treatment of bronchial asthma. The formulation may be delivered by a metered dose inhaler with a canister that is inert to flunisolide.
Other References
Gennaro, A. R. (1985). Remington's Pharmaceutical Sciences. Mack Publishing Co., pp. 1670-1677
Moren, F. et al. (1993). Aerosols in Medicine: Princples, Deagnosis and Therapy. Elsevier, pp. 303-319
The Theory and Practice of Industrial Pharmacy, Leon Lachman et al., 3rd Ed., Lea & Febiger 1986, Chapter 20, pp. 597, 599 and 603
The Theory and Practice of Industrial Pharmacy, 2nd Edition, 1976, Lea & Febiger, Philadelphia, pp. 270 and 276-28
July 7, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
